Mixed Titer Performance Panel.
An Anti-Dengue Mixed Titer Performance Panel has recently been launched by SeraCare as its first commercially available line of infectious disease panels responding to the demand for accurate testing for dengue virus. It is designed to help blood donor collection facilities, diagnostics manufacturers, and clinical laboratories evaluate and troubleshoot their anti-dengue virus assays. The new performance panel is derived from undiluted, unpreserved human plasma specimens, with 21 members representing a wide range of reactivity for anti-dengue IgM and IgG antibodies, from negative to strongly positive. Panel members include samples from individuals with recent and past infection by all four dengue viruses.
SeraCare Life Sciences Visit www.rsleads.com/209m1-155
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Blood banking and transfusion|
|Publication:||Medical Laboratory Observer|
|Article Type:||Brief article|
|Date:||Sep 1, 2012|
|Previous Article:||Trackable Ergonomic Carrier.|
|Next Article:||Accurate donor screening.|